Navigation Links
Biopharma Leaders Unite to Share Real-Life Business Development Experiences at LeadingBiotech’s Boston BD Conference
Date:7/26/2019

LeadingBiotech, an exclusive event series bringing together senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces its Boston BD conference to be held on September 10, 2019, at the Westin Boston Waterfront Hotel. As part of Biotech Week Boston, the event provides an opportunity for attendees to leverage insight from real-life business development experiences, network with biopharma executives and share insights on the business challenges and opportunities impacting the industry.

"It’s a great conference to meet like-minded people working in the same space. Excellent for networking and thought-provoking discussion," commented Lesley Solomon, SVP Innovation, Chief Innovation Officer, Dana-Farber Cancer Institute, and a speaker at this year’s event.

Key topics at this year’s conference include Improving Patients Lives & Re-Defining Value, Pioneering New Business Models for Creative Deal Structures, and a fireside chat on True Collaborations Between Companies.

Keynote speakers at the conference include:

  • Mary Lynne Hedley, Ph.D., President and COO, TESARO
  • Jeb Keiper, M.S., M.B.A., CEO, Nimbus Therapeutics
  • David K. Lee, CEO, Servier Pharmaceuticals
  • Lonnie Moulder, Founding General Partner, Tellus BioVentures and Venture Advisor, NEA
  • Praveen Tipirneni, President and CEO, Morphic Therapeutics
  • James Tobin, Ph.D., Vice President, Cardiovascular and Metabolic Scientific Innovation, Johnson & Johnson Innovation?

Other new speakers include

  • Kerrie Brady, BPharm, M.S., M.B.A.,?CBO & EVP, Corporate Strategy,?Centrexion?Therapeutics?
  • Michelle Doig, Partner, Omega Funds
  • Elcin Ergun, M.B.A., EVP, President New Business, EMD Serono
  • Bill Geary, Co-Founder & General Partner, Flare Capital Partners
  • Sophie Kornowski, Senior Partner, Gurnet Point Capital
  • Reenie McCarthy, CEO,?Stealth?BioTherapeutics
  • Ronald Renaud, CEO, Translate Bio
  • Lesley Solomon, SVP Innovation, Chief Innovation Officer, Dana-Farber Cancer Institute
  • Alex Waldron, Chief Strategy Officer, Pear Therapeutics

Save $400 with the early bird rate if you register before August 1. Reserve your spot now.

Nominate a Rising Star in the Biopharma Community:
New this year, LeadingBiotech is accepting nominations for a Rising Star, an experienced executive who is an up-and-coming mover and shaker in the biopharma community. Nominations are being accepted through August 15, 2019. The elected Rising Star will receive a complimentary pass to Boston BD. Nominate someone for this recognition here.

About LeadingBiotech
Formerly known as Boston Biotech Conferences, LeadingBiotech is an event series that brings biopharma CEOs and leaders together through intimate, off-the-record collaboration. We are working hard to create more valuable experiences to re-energize collaboration and infuse fresh ideas to better shape the future of biotech. For more information, please visit: https://leadingbiotech.com/.

Read the full story at https://www.prweb.com/releases/biopharma_leaders_unite_to_share_real_life_business_development_experiences_at_leadingbiotechs_boston_bd_conference/prweb16463525.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. VetStem Biopharma Heavily Featured in Recent Documentary About Regenerative Medicine for Domestic and Wild Animals
2. VetStem Biopharma, Parent Company of Personalized Stem Cells, is Approved for Stem Cell Manufacturing by the California Department of Public Health
3. VetStem Biopharma Shares the Story of Atlas Who Was Successfully Treated with VetStem Cell Therapy by Dr. Colter Negranti
4. VetStem Biopharma Shares the Success Story of Frank who was Treated with VetStem Cell Therapy by Pain Management Specialist Dr. Jamie Gaynor
5. VetStem Biopharma Shares the Story of Sonny Bar Lisa Who Was Successfully Treated With VetStem Cell Therapy
6. LeadingBiotech’s Boston CEO Conference Unites Biopharma Leaders May 28-29 at Four Seasons Hotel
7. VetStem Biopharma is Pleased to Share the Success Story of Bogey Who Was Treated with VetStem Cell Therapy by Dr. Ava DeCozio
8. VetStem Biopharma Shares the Story of San Fransisko Who Advanced in His Dressage Career After Being Treated with VetStem Cell Therapy
9. VetStem Biopharma Launches Human Stem Cell Company in San Diego
10. VetStem Biopharma is Pleased to Announce Dr. Douglas Stramel of Advanced Care Veterinary Services is Successfully Using the Pall V-PET™ Platelet Therapy System
11. VetStem Biopharma is Pleased to Share the Success Story of Rascal who was Treated with VetStem Cell Therapy by Dr. Deborah Fegan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2019)... ... 2019 , ... The summer season has been super busy ... has the company already hosted many of its signature cooking classes and team-building ... , With Lajollacooks4u’s Private Cooking Parties, guests prepare and enjoy a variety of ...
(Date:7/19/2019)... Calif. (PRWEB) , ... July 18, 2019 , ... ... also known as “Ravi Everest,” will be joining forces with California-based charity Coalition ... held from July 20-22nd. Coalition Duchenne raises awareness and funding for Duchenne muscular ...
(Date:7/11/2019)... , ... July 11, 2019 , ... At the most ... complimentary regenerative therapies to eight military Veterans under the R3 Heroes Program. The Veterans ... , The R3 Heroes Program allow anyone to nominate a military Veteran, teacher or ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research ... physicochemical properties of Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. ... characteristic differentiation peak, change in crystallite size , Over 142% increase in ...
Breaking Biology Technology:
(Date:7/23/2019)... (PRWEB) , ... July 23, 2019 , ... ... provides personalized, easy-to-understand, web-based genetic counseling, today announced that the company has expanded ... to MUTYH-associated polyposis (MAP), familial hypercholesterolemia (FH), and Parkinson’s disease. , The expanded ...
(Date:7/19/2019)... ... 2019 , ... VetStem Biopharma has long been a leader in ... result of a two-year research collaboration with Calidi Biotherapeutics, VetStem has signed a worldwide ... VetStem should be able to fast-track this cancer therapy for use in dogs ...
(Date:7/17/2019)... Pa. (PRWEB) , ... July 15, 2019 , ... ... of computational science expertise exclusively for Life Sciences and Healthcare companies, announces the ... provide critical advisory services and strategic direction to start-up and emerging bio-pharma companies ...
Breaking Biology News(10 mins):